DUGGAN ROBERT W bought SMMT
January 2, 2026 · Form 4 insider transaction
DUGGAN ROBERT W bought 11,232 shares of Summit Therapeutics Inc. at $8.76 per share, a transaction worth $98.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,232
Price
$8.76
Total value
$98.4K
InsiderDUGGAN ROBERT W
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after11,232
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400.; The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.